Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionNorthRock Partners, LLC
Latest Disclosed Ownership16,038 shares
Latest Disclosed Value $ 1,284,399
NorthRock Partners, LLC reports 3.41% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 15, 2026 - NorthRock Partners, LLC filed a 13F-HR form disclosing ownership of 16,038 shares of Edwards Lifesciences Corporation (MX:EW) valued at $1,284,399 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 16,605 shares of Edwards Lifesciences Corporation. This represents a change in shares of -3.41% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 16,038 -567 -3.41 1,284 -9.26 0.0207
2026-02-17 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 16,605 -8,922 -34.95 1,416 -28.72 0.0239
2025-11-14 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 25,527 2,822 12.43 1,985 11.83 0.0358
2025-11-14 2025-06-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 22,705 2,650 13.21 1,776 22.16 0.0462
2025-07-25 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 22,705 2,650 1,776 0.0459
2025-05-08 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 20,055 -42 -0.21 1,454 -2.29 0.0488
2025-04-22 2024-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 20,097 2,040 11.30 1,488 24.85 0.0485
2025-02-14 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 20,097 2,040 1,488 0.0486
2025-04-22 2024-09-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 18,057 -1,991 -9.93 1,192 -35.66 0.0392
2024-10-30 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 9,914 -10,134 654 0.0578
2025-04-22 2024-06-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 20,048 757 3.92 1,852 0.43 0.0696
2024-08-06 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,658 -7,633 1,077 0.0965
2025-04-22 2024-03-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 19,291 640 3.43 1,843 29.61 0.0707
2024-05-07 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 13,847 -4,804 1,323 0.1120
2025-04-22 2023-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 18,651 5,149 38.14 1,422 52.09 0.0595
2024-02-08 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 13,143 -359 1,002 0.0935
2023-10-24 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 13,502 -1,154 -7.87 935 -32.34 0.0976
2023-08-02 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 14,656 -527 -3.47 1,382 10.03 0.1514
2023-05-04 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 15,183 958 6.73 1,256 18.38 0.1337
2023-02-01 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 14,225 -1,220 -7.90 1,061 -16.85 0.1208
2022-11-02 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 15,445 -595 -3.71 1,276 -16.33 0.1483
2022-08-04 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 16,040 1,753 12.27 1,525 -9.33 0.1585
2022-05-05 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 14,287 -2,757 -16.18 1,682 -23.82 0.1513
2022-02-07 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 17,044 383 2.30 2,208 17.07 0.1654
2021-11-12 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 16,661 824 5.20 1,886 15.00 0.1542
2021-08-12 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 15,837 -1,346 -7.83 1,640 14.13 0.1370
2021-05-11 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 17,183 -168 -0.97 1,437 -9.22 0.1307
2021-02-08 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 17,351 -1,442 -7.67 1,583 5.53 0.1560
2020-11-12 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 18,793 243 1.31 1,500 17.00 0.1664
2020-08-13 2020-06-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 18,550 12,322 197.85 1,282 9.11 0.1519
2020-08-11 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 18,552 12,324 1,282 151,798.4325
2020-05-13 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,228 -107 -1.69 1,175 -20.50 0.1646
2020-02-12 2019-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 6,335 776 13.96 1,478 20.95 0.1561
2020-02-12 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,336 777 1,478 156,127.2004
2019-11-12 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 5,559 5,559 1,222 0.1666
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.